HI
BIIB icon

Humankind Investments’s Biogen BIIB Stock Holding History

Humankind Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,867
Closed -$402K – 40
2025
Q3 		$402K Sell
2,867
-172
-6% -$23.3K 0.09% 93
2025
Q2 		$382K Sell
3,039
-458
-13% -$57.1K 0.09% 92
2025
Q1 		$479K Buy
3,497
+487
+16% +$69.6K 0.12% 88
2024
Q4 		$460K Buy
3,010
+739
+33% +$125K 0.12% 90
2024
Q3 		$440K Buy
2,271
+367
+19% +$76.8K 0.16% 86
2024
Q2 		$441K Sell
1,904
-283
-13% -$61.5K 0.12% 87
2024
Q1 		$472K Buy
2,187
+247
+13% +$57.8K 0.12% 83
2023
Q4 		$502K Buy
1,940
+346
+22% +$85K 0.15% 71
2023
Q3 		$410K Buy
1,594
+231
+17% +$61.8K 0.17% 72
2023
Q2 		$388K Sell
1,363
-844
-38% -$251K 0.15% 77
2023
Q1 		$614K Buy
2,207
+186
+9% +$51.5K 0.25% 61
2022
Q4 		$560K Sell
2,021
-828
-29% -$234K 0.24% 62
2022
Q3 		$761K Buy
2,849
+282
+11% +$59.9K 0.37% 42
2022
Q2 		$524K Buy
2,567
+36
+1% +$7.36K 0.25% 60
2022
Q1 		$533K Buy
2,531
+556
+28% +$121K 0.22% 59
2021
Q4 		$474K Buy
1,975
+637
+48% +$164K 0.6% 56
2021
Q3 		$379K Buy
1,338
+72
+6% +$23.6K 0.58% 60
2021
Q2 		$438K Buy
1,266
+425
+51% +$129K 0.78% 42
2021
Q1 		$235K Buy
+841
New +$227K 0.72% 53

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Humankind Investments's BIIB Position: Q4 2025 in Review

Humankind Investments sold out of Biogen (BIIB) in Q4 2025, closing a stake of 2,867 shares — an estimated $402K sold.

Humankind Investments first reported a position in BIIB in Q1 2021 and held it in 19 quarters. The position peaked at $761K in Q3 2022. 997 funds tracked by Wall St. Rank hold BIIB as of Q4 2025.

  • Humankind Investments reported no remaining Biogen position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 2,867 Biogen shares in Q4 2025, an estimated $402K.
  • Humankind Investments first reported a position in Biogen in Q1 2021 and held it in 19 quarters.
  • Humankind Investments's Biogen position peaked at $761K in Q3 2022.
  • 997 funds tracked by Wall St. Rank held Biogen as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.